MedPath
FDA Approval

Duetact

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
October 24, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pioglitazone(30 mg in 1 1)
Glimepiride(4 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Takeda GmbH

Takeda Pharmaceuticals America, Inc.

313270015

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Duetact

Product Details

NDC Product Code
64764-304
Application Number
NDA021925
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
June 1, 2020
Code: JQT35NPK6CClass: ACTIMQuantity: 30 mg in 1 1
Code: 6KY687524KClass: ACTIBQuantity: 4 mg in 1 1
croscarmellose sodiumInactive
Code: M28OL1HH48Class: IACT
lactose monohydrateInactive
Code: EWQ57Q8I5XClass: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
microcrystalline celluloseInactive
Code: OP1R32D61UClass: IACT

Duetact

Product Details

NDC Product Code
64764-302
Application Number
NDA021925
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
June 1, 2020
magnesium stearateInactive
Code: 70097M6I30Class: IACT
Code: JQT35NPK6CClass: ACTIMQuantity: 30 mg in 1 1
croscarmellose sodiumInactive
Code: M28OL1HH48Class: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
Code: 6KY687524KClass: ACTIBQuantity: 2 mg in 1 1
lactose monohydrateInactive
Code: EWQ57Q8I5XClass: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
microcrystalline celluloseInactive
Code: OP1R32D61UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath